PubMed:32801842 / 1076-1332 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T31","span":{"begin":0,"end":15},"obj":"UBERON:0002280"},{"id":"T32","span":{"begin":53,"end":61},"obj":"CHEBI:60809"},{"id":"T33","span":{"begin":53,"end":61},"obj":"CHEBI:60809"},{"id":"T34","span":{"begin":95,"end":100},"obj":"CHEBI:36044"},{"id":"T35","span":{"begin":95,"end":100},"obj":"CHEBI:36044"},{"id":"T36","span":{"begin":180,"end":197},"obj":"UBERON:0002280"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Otolaryngologic treatment mainly involves supportive adjuvant usage of interferon or antiviral drugs; however, approximately one-third of patients may not survive, and, therefore, otolaryngologists should be familiar with and remain mindful of the disease."}

{"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":256},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":256},"obj":"Sentence"}],"text":"Otolaryngologic treatment mainly involves supportive adjuvant usage of interferon or antiviral drugs; however, approximately one-third of patients may not survive, and, therefore, otolaryngologists should be familiar with and remain mindful of the disease."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":53,"end":61},"obj":"Chemical"},{"id":"T5","span":{"begin":71,"end":81},"obj":"Chemical"},{"id":"T6","span":{"begin":85,"end":100},"obj":"Chemical"},{"id":"T7","span":{"begin":85,"end":94},"obj":"Chemical"},{"id":"T8","span":{"begin":95,"end":100},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Otolaryngologic treatment mainly involves supportive adjuvant usage of interferon or antiviral drugs; however, approximately one-third of patients may not survive, and, therefore, otolaryngologists should be familiar with and remain mindful of the disease."}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":256},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Otolaryngologic treatment mainly involves supportive adjuvant usage of interferon or antiviral drugs; however, approximately one-third of patients may not survive, and, therefore, otolaryngologists should be familiar with and remain mindful of the disease."}

{"project":"LitCovid-PubTator","denotations":[{"id":"31","span":{"begin":138,"end":146},"obj":"Species"}],"attributes":[{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Otolaryngologic treatment mainly involves supportive adjuvant usage of interferon or antiviral drugs; however, approximately one-third of patients may not survive, and, therefore, otolaryngologists should be familiar with and remain mindful of the disease."}